កំពុងផ្ទុក

Slzii.com ស្វែងរក

ស្វែងរក (ព័ត៌មាន)

New England Journal Of Medicine Publishes Positive Phase 3 VALOR Trial Results Of Brepocitinib In Dermatomyositis

top health

(MENAFN - GlobeNewsWire - Nasdaq) The results of the Phase 3 VALOR trial were published in the New England Journal of Medicine, underscoring the practice-changing potential of brepocitinib 30 mg ...
2026-03-28 15:15:53

តើអ្នកកំពុងធ្វើអ្វី?

0.075603008270264


ព័ត៌មាន
ព័ត៌មាន

ព័ត៌មានថ្មីៗ និងចំណងជើង
(MENAFN - GlobeNewsWire - Nasdaq) The results of the Phase 3 VALOR trial were published in the New England Journal of Medicine, underscoring...
ព័ត៌មាន